When the mean and LSM values were separated, the pooled results also showed that roxadustat significantly raised the Hb level both in the DD-CKD patients (online Supplementary Figure S1A) and in the NDD-CKD patients (online Supplementary Figure S1B). This evidence concerns the gene GSTM1 and chronic kidney disease.